Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2 Meeting Abstract
| Authors: | Barlesi, F.; Drilon, A.; De Braud, F.; Cho, B. C.; Ahn, M. J.; Siena, S.; Krebs, M. G.; Lin, C. C.; John, T.; Tan, D. S. W.; Seto, T.; Dziadziuszko, R.; Arkenau, H. T.; Rolfo, C.; Wolf, J.; Ye, C.; Riehl, T.; Eng, S.; Doebele, R. C. |
| Abstract Title: | Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2 |
| Meeting Title: | 2018 European Lung Cancer Congress (ELCC) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Apr 10-13 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-04-01 |
| Start Page: | mdz063.007 |
| Language: | English |
| ACCESSION: | WOS:000478089000108 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz063.007 |
| Notes: | Meeting Abstract: 109O -- Appears on pages ii42-ii43 of the abstract book -- Source: Wos |
